Filter Results
:
(920)
Show Results For
-
All HBS Web
(920)
- People (2)
- News (61)
- Research (752)
- Events (1)
- Multimedia (2)
- Faculty Publications (643)
Show Results For
-
All HBS Web
(920)
- People (2)
- News (61)
- Research (752)
- Events (1)
- Multimedia (2)
- Faculty Publications (643)
- 05 Sep 2007
- First Look
First Look: September 5, 2007
findings, we consider both information and social factors. We find that firms are more likely to protect proximate employees in soft information industries (i.e., when information is difficult to transfer over long distances). However,...
View Details
Keywords:
Martha Lagace
- 03 Nov 2015
- First Look
November 3, 2015
quantify the impact of scientific grant funding at the National Institutes of Health (NIH) on patenting by pharmaceutical and biotechnology firms. Our paper makes two contributions. First, we use newly constructed bibliometric data to...
View Details
Keywords:
Sean Silverthorne
- January 2007 (Revised January 2007)
- Background Note
Note on the U.S. Food and Drug Administration
By: Robert F. Higgins, Richard G. Hamermesh and Virginia Fuller
Describes the U.S. FDA with particular emphasis on its role in the development of new drugs, biologic products, and medical devices today. Provides context for the drug approval process by describing the FDA's history and organizational structure.
View Details
Keywords:
Health;
Governance Compliance;
Policy;
Product Development;
Government and Politics;
Pharmaceutical Industry;
Pharmaceutical Industry;
Pharmaceutical Industry;
Pharmaceutical Industry;
United States
Higgins, Robert F., Richard G. Hamermesh, and Virginia Fuller. "Note on the U.S. Food and Drug Administration." Harvard Business School Background Note 807-050, January 2007. (Revised January 2007.)
- March 2015
- Teaching Note
CVS Health: Promoting Drug Adherence
Email mking@hbs.edu for a courtesy copy.
This Teaching Note explains the theory of the case and teaching plan for the case: CVS Health: Promoting Drug Adherence (515010). The case finds Helena Foulkes, Executive... View Details
This Teaching Note explains the theory of the case and teaching plan for the case: CVS Health: Promoting Drug Adherence (515010). The case finds Helena Foulkes, Executive... View Details
Keywords:
Medication Adherence;
Affordable Care Act (ACA);
Marketing Strategy;
Communication Strategy;
Customer Value and Value Chain;
Decisions;
Health Care and Treatment;
Goals and Objectives;
Resource Allocation;
Marketing Communications;
Consumer Behavior;
Measurement and Metrics;
Service Delivery;
Behavior;
Motivation and Incentives;
Social Issues;
Information Technology;
Value Creation;
Health Industry;
Health Industry;
Health Industry;
Health Industry;
Health Industry;
United States
John, Leslie, John Quelch, and Robert Huckman. "CVS Health: Promoting Drug Adherence." Harvard Business School Teaching Note 515-086, March 2015. (Email mking@hbs.edu for a courtesy copy.)
- April 2022
- Teaching Note
CVS Health: Prescription for Transformation
By: Rosabeth Moss Kanter and Catarina Martinez
In 2021, new CEO Karen Lynch (named the most powerful woman in business) considered the next transformation phase for CVS Health (a Fortune 5 corporate giant). The 2018 acquisition of Aetna insurance brought her to the company as part of its long evolution from a...
View Details
- May 2018
- Case
The Multiple Myeloma Research Foundation's Answer Fund
By: Richard G. Hamermesh and Matthew G. Preble
Keywords:
Data Analytics;
Customer Focus and Relationships;
Customer Relationship Management;
Cost vs Benefits;
Investment Return;
Health Care and Treatment;
Innovation Leadership;
Intellectual Property;
Knowledge Sharing;
Knowledge Dissemination;
Leadership;
Leading Change;
Resource Allocation;
Goals and Objectives;
Marketing Communications;
Performance;
Programs;
Projects;
Business and Community Relations;
Business and Stakeholder Relations;
Networks;
Partners and Partnerships;
Research and Development;
Genetics;
Behavior;
Motivation and Incentives;
Social and Collaborative Networks;
Nonprofit Organizations;
Strategy;
Health Industry;
Health Industry;
Health Industry;
United States
- 07 Oct 2014
- First Look
First Look: October 7
(MMRC), and brought together a diverse body of academics, researchers, pharmaceutical and biotech companies, physicians, and patients to combine their efforts around the disease. The MMRF had helped facilitate clinical trials for...
View Details
Keywords:
Sean Silverthorne
- 10 Sep 2007
- Research & Ideas
High Note: Managing the Medici String Quartet
The panel consisted of Bob Frosch, who used to head NASA and R&D for GM; Vicki Sato, who was president of Vertex Pharmaceuticals and is now on the HBS faculty; and Peter Hanke, a conductor. These people have had a lot of experience...
View Details
- 02 Aug 2018
- News
Can Marketing Help Halt the Heroin Epidemic?
going to take care of themselves, meaning prescriber limits are coming down, the way that doctors are prescribing is changing, CDC have got guidelines, lawsuits against these pharmaceutical companies and the distributors. All those things...
View Details
- 03 Mar 2009
- First Look
First Look: March 3, 2009
presence of strategic interactions between content distributors and content providers. We provide a model of bargaining and price competition within these industries and show that whether or not a piece of content ends up exclusive to one...
View Details
Keywords:
Martha Lagace
- 15 Dec 2015
- News
The Year in Ideas 2015
most nimble creators will move from a mobile-first to a mobile-only approach. “The strongest brands will continue to do what they do best—superserve their audiences—but the native advertising model will meaningfully challenge the existing, archaic advertising model,...
View Details
- 05 Aug 2008
- First Look
First Look: August 5, 2008
analyses of data covering 69 two-digit SIC industries at two points in time, 1991 and 1999. Across industries, we find that the likelihood of internalization of advertising services decreases as the size of advertising outlays increase...
View Details
Keywords:
Martha Lagace
- 07 Apr 2003
- Research & Ideas
XTV: Xerox’s Attempted Recovery From “Fumbling the Future”
because they were built with proprietary components, a manifestation of Xerox's approach to systems design. The development costs of these proprietary components had to be borne by the low unit volumes of its printers, in contrast to View Details
Keywords:
by Henry Chesbrough
- 01 Sep 2014
- News
All For One
industries as diverse as automobiles and pharmaceuticals and began to interview and observe them to see how they created environments ripe for innovation. “We didn’t want to just espouse platitudes,” Hill...
View Details
- 12 Apr 2010
- Research & Ideas
One Report: Better Strategy through Integrated Reporting
electronics company Philips; the Danish pharmaceutical company Novo Nordisk; the Brazilian cosmetics company Natura; and the U.S.-based technology and aerospace company United Technologies all come to mind. All have done a very good job...
View Details
Keywords:
by Martha Lagace
- Web
Podcast - Managing the Future of Work
Institute, Joe Fuller. My guest today is Kelly Services CEO, Peter Quigley, who’s been with the company almost two decades. We’ll talk about changes in the industry over time, how companies are navigating the tight labor market, and how...
View Details
- October 2020 (Revised April 2022)
- Case
When Institutions Fail: HIV/AIDS in the 1980s
By: Tom Nicholas and Christian Godwin
During the early 1980s, young gay men in urban centers such as San Francisco and New York City began contracting a mysterious illness that would come to be known as HIV/AIDS. A diagnosis meant almost certain death, with a less than 1% survival rate. Conflicting...
View Details
Keywords:
Ethics;
Policy;
Government and Politics;
Health Pandemics;
History;
Rights;
Media;
Organizations;
Business and Community Relations;
Religion;
Social Psychology;
Identity;
Prejudice and Bias;
Social Issues;
Public Opinion;
Pharmaceutical Industry;
Pharmaceutical Industry;
Pharmaceutical Industry;
Pharmaceutical Industry;
Pharmaceutical Industry;
Pharmaceutical Industry;
United States
Nicholas, Tom, and Christian Godwin. "When Institutions Fail: HIV/AIDS in the 1980s." Harvard Business School Case 821-002, October 2020. (Revised April 2022.)
- July 2013 (Revised November 2021)
- Module Note
Exploration vs. Exploitation
By: Willy Shih
This module note introduces James March's concept of exploration and exploitation, and the management challenge of balancing the allocation of resources to the two activities in the firm. The note also touches on the O'Reilly and Tushman paper on the ambidextrous...
View Details
Keywords:
Exploration And Exploitation;
Exploitation;
Research;
Scientific Research;
Product Commercialization;
Innovation and Invention;
Innovation and Management;
Innovation Leadership;
Innovation Strategy;
Technological Innovation;
Knowledge Acquisition;
Growth and Development Strategy;
Resource Allocation;
Strategic Planning;
Research and Development;
Science-Based Business;
Corporate Strategy;
Knowledge Sharing;
Biotechnology Industry;
Biotechnology Industry;
Biotechnology Industry;
Biotechnology Industry;
Biotechnology Industry;
Biotechnology Industry;
Biotechnology Industry;
United States
Shih, Willy. "Exploration vs. Exploitation." Harvard Business School Module Note 614-004, July 2013. (Revised November 2021.)
- 29 Jan 2013
- First Look
First Look: Jan. 29
considers the effect of consolidation within the industry on firm value. Purchase this case:http://hbr.org/search/213065-PDF-ENG Sirtris Pharmaceuticals: Living Healthier, Longer (Abridged) Stuart, Toby, and James WeberHarvard Business...
View Details
Keywords:
Sean Silverthorne
- 19 Jan 2023
- News
Forged in Fire
Subscribe on iTunes Subscribe on Spotify More Skydeck episodes Hi, this is Dan Morrell, host of Skydeck. When he was just three years old, Chad Foster (PLDA 21, 2016) was diagnosed with retinitis pigmentosa, a degenerative condition that would ultimately leave him...
View Details